resveratrol has been researched along with Libman-Sacks Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, A; Pannu, N | 2 |
| Chen, SJ; Huang, DY; Huang, HY; Jhou, JP; Lin, WW; Tzeng, SJ | 1 |
| Chen, HZ; Chen, Z; Gao, N; Li, MT; Luo, XF; Wang, ZL; Xu, D; Zeng, XF; Zhang, LL; Zhou, S | 1 |
| Carsons, SE; DeLeon, J; Fazzari, MJ; Littlefield, MJ; Reiss, AB; Siegart, NM; Teboul, I; Turi, GK; Voloshyna, I | 1 |
5 other study(ies) available for resveratrol and Libman-Sacks Disease
| Article | Year |
|---|---|
Combinatorial therapeutic effect of resveratrol and piperine on murine model of systemic lupus erythematosus.
Topics: Alkaloids; Animals; Autoantibodies; Benzodioxoles; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Piperidines; Polyunsaturated Alkamides; Resveratrol; Terpenes; Treatment Outcome | 2020 |
Prophylactic effect of resveratrol and piperine on pristane-induced murine model of lupus-like disease.
Topics: Alkaloids; Animals; Antioxidants; Benzodioxoles; Cytokines; Disease Models, Animal; Female; Inflammation; Kidney; Lipid Peroxidation; Liver; Lung; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Resveratrol; Terpenes | 2020 |
Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.
Topics: Animals; Anti-Inflammatory Agents; Autoantibodies; B-Lymphocytes; Cell Membrane; Disease Models, Animal; Gene Expression Regulation; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Models, Biological; Myeloid Cells; NF-kappa B; Promoter Regions, Genetic; Receptors, IgG; Resveratrol; Splenomegaly; Stilbenes; Survival Rate; Transcriptional Activation | 2017 |
Resveratrol possesses protective effects in a pristane-induced lupus mouse model.
Topics: Animals; Antigens, CD; Antigens, CD19; Antigens, Differentiation, T-Lymphocyte; Apoptosis; B-Lymphocytes; CD4-Positive T-Lymphocytes; Gene Expression Regulation; Humans; Inflammation; Lectins, C-Type; Lupus Erythematosus, Systemic; Mice; Receptors, Transferrin; Resveratrol; Sirtuin 1; Stilbenes; Terpenes | 2014 |
Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cholesterol; fas Receptor; Humans; Lupus Erythematosus, Systemic; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Resveratrol; Stilbenes | 2016 |